Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review.
Mohamed HanyAnwar Ashraf AbouelnasrMohamed Hesham AbdelkhalekMohamed IbrahimMostafa R AboelsoudAdel Ibrahim HozienBart TorensmaPublished in: International journal of obesity (2005) (2023)
For the first time, BMS has been tested in treating both OSA and NAFLD pre and postoperative with positive results. Further research, ideally with histological and functional data, is needed to confirm these findings. The SR identified 14 distinct liver outcome tests; however, high heterogeneity and incomplete data precluded a meta-analysis. It is imperative to pay greater attention to the influence of OSA-related factors and uniformity in liver outcomes testing concerning NAFLD. To accomplish this, study designs should be enhanced by incorporating more comprehensive pre- and postoperative evaluations, extending follow-up periods, and employing a more consistent methodology for liver diagnosis in patients with obesity.
Keyphrases
- obstructive sleep apnea
- positive airway pressure
- metabolic syndrome
- insulin resistance
- weight loss
- patients undergoing
- type diabetes
- electronic health record
- weight gain
- high fat diet induced
- big data
- single cell
- working memory
- sleep apnea
- machine learning
- skeletal muscle
- data analysis
- liver fibrosis
- glycemic control